In The News

Dr. Greg Everson Speaks at PSC Forum 9 in Washington, DC

Dr. Greg T. Everson presented at the annual PSC Forum 9 in Washington, DC, sharing how the oral cholate challenge test can help clinicians more accurately assess disease severity in patients with primary sclerosing cholangitis (PSC). Click here to see his presentation.

September 10, 2025

HepQuant DuO™ Estimates Risk for Clinical Outcome and Quantifies Changes in Risk

Dr. Greg Everson just shared groundbreaking insights at the Liver Forum in Paris! His presentation highlights how HepQuant DuO™ helps estimate clinical risk and track changes over time — a major step forward in liver disease management. [View his presentation here.]

April 23, 2025

HepQuant Celebrates Lab Week 2025!

Our amazing lab team is the backbone of our company, powering innovation, precision, and progress every single day. Their dedication to science, quality, and patient impact makes everything we do possible. This week, we recognize and thank our lab professionals for their hard work behind the scenes—advancing liver disease diagnostics and helping improve lives. 🔬 Here’s to the problem solvers, data champions, and science heroes in the lab. We appreciate you today and every day!